Overview

A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.

Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to evaluate the safety of Ginkgolides Meglumine Injection in the treatment of ischemic stroke with Syndrome of Intermingled Phlegm and Blood Stasis.
Phase:
Phase 4
Details
Lead Sponsor:
Jiangsu Kanion Pharmaceutical Co., Ltd
Collaborator:
Beijing Bionovo Medicine Development Co., Ltd.